Obstructive Sleep Apnea Clinical Trials in New York, New York

4 studies are recruiting for obstructive sleep apnea in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

    The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older adults recruited from well-established sleep clinics at 4 academic medical centers, with newly dia…

    Stage
    Not phased
    Ages
    55 to 85
    Site
    New York University, New York, New York
    Locations
    4 in total
    Run by
    California Pacific Medical Center Research Institute

    See if you can join NCT05988385 on ClinicalTrials.gov

  2. Severe Label Expansion for EVO Products Trial

    Title: Severe Label Expansion for EVO Positioner (SLEEP) Study Description: Single-arm study to determine the safety and effectiveness of treating severe obstructive sleep apnea using the EVO Sleep and Snore Device (ProSomnus Sleep Technologies, Pleasanton, CA). Objectives: To determine the safety …

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Mount Sinai Integrative Sleep Center, New York, New York
    Locations
    2 in total
    Run by
    ProSomnus Sleep Technologies

    See if you can join NCT07090395 on ClinicalTrials.gov

  3. Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness

    Obstructive sleep apnea (OSA) is a sleep disorder that is commonly treated using positive airway pressure, yet 50% of patients still experience residual sleepiness after successful therapy. A potential neuromodulation strategy that can decrease residual sleepiness is transcranial photobiomodulation…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    NYU Langone Health, New York, New York
    Run by
    NYU Langone Health

    See if you can join NCT06698809 on ClinicalTrials.gov

  4. Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

    Hypoglossal nerve stimulation (HGNS) is an implantable therapy that treats obstructive sleep apnea. The study will evaluate the effect of this treatment on cardiovascular and metabolism-related measures to see if it affects patients' risk of medical problems associated with obstructive sleep apnea …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Columbia University Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT06720545 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.